Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine Augmentation for Adolescent Females With Treatment-Resistant MDD
NCT02134808Phase 4Completed
- Start
- Nov 2014
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of creatine in major depressive disorder (MDD). Started Nov 2014; status: completed.
02
Drugs
creatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02134808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134808.